Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
Clinical trial NCT00365937 · TERMINATED
Trial details
- NCT number
- NCT00365937
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2013-12-13
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.